Cardlytics Grants 1 Million RSUs to New CFO as Inducement Award

Reuters01-17
Cardlytics Grants 1 Million RSUs to New CFO as Inducement Award

Cardlytics Inc. has announced that its newly appointed Chief Financial Officer, David Evans, has been granted 1,000,000 restricted stock units under the company’s 2022 Inducement Plan. Half of the units will vest on February 1, 2027, with the remaining 50% vesting quarterly over the following 12 months, contingent on Evans’ continued service with Cardlytics through each vesting date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardlytics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260116071716) on January 16, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment